BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15094933)

  • 21. Renoprotect and blood pressure lowering effect of low-dose hydrochlorothiazide added to intensive renin-angiotensin inhibition in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Int J Clin Pharmacol Ther; 2009 Aug; 47(8):525-32. PubMed ID: 19640361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Losartan reduces monocyte chemoattractant protein-1 expression in aortic tissues of 2K1C hypertensive rats.
    Xie QY; Sun M; Yang TL; Sun ZL
    Int J Cardiol; 2006 Jun; 110(1):60-6. PubMed ID: 16242797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus.
    Derosa G; Mugellini A; Pesce RM; D'Angelo A; Maffioli P
    BMC Cardiovasc Disord; 2016 Apr; 16():66. PubMed ID: 27068332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats.
    Rehman A; Leibowitz A; Yamamoto N; Rautureau Y; Paradis P; Schiffrin EL
    Hypertension; 2012 Feb; 59(2):291-9. PubMed ID: 22184324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the angiotensin II type 1 receptor antagonist telmisartan on monocyte adhesion and activation in patients with essential hypertension.
    Syrbe U; Moebes A; Scholze J; Swidsinski A; Dörffel Y
    Hypertens Res; 2007 Jun; 30(6):521-8. PubMed ID: 17664855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
    Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker on Diastolic Function in Hypertensive Patients.
    Toh N; Ishii K; Kihara H; Iwakura K; Watanabe H; Yoshikawa J; Ito H;
    Circ J; 2016; 80(2):426-34. PubMed ID: 26725762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
    Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
    Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 diabetes mellitus complicated by hypertension in Japanese patients: switching treatment from high-dose angiotensin II receptor blockers to losartan plus hydrochlorothiazide.
    Yamamoto S; Okada Y; Mori H; Nishida K; Uriu K; Tanaka Y
    Intern Med; 2014; 53(12):1283-9. PubMed ID: 24930646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis.
    Fogari R; Maffioli P; Mugellini A; Zoppi A; Lazzari P; Derosa G
    Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):164-71. PubMed ID: 22081005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
    Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial.
    Scaglione R; Argano C; Corrao S; Di Chiara T; Licata A; Licata G
    J Hypertens; 2005 Mar; 23(3):657-64. PubMed ID: 15716710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1.
    Jilma B; Li-Saw-Hee FL; Wagner OF; Beevers DG; Lip GY
    Clin Sci (Lond); 2002 Aug; 103(2):131-6. PubMed ID: 12149103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of high-risk hypertensive patients with diabetes: potential role of angiotensin II receptor antagonists.
    Weber MA; Weir MR
    J Clin Hypertens (Greenwich); 2001; 3(4):225-35. PubMed ID: 11498653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
    Kalliovalkama J; Kähönen M; Tolvanen JP; Wu X; Voipio J; Pekki A; Doris PA; Ylitalo P; Pörsti I
    Pharmacol Toxicol; 2000 Jan; 86(1):36-43. PubMed ID: 10720105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of AT1 receptor blockade on blood pressure, renal haemodynamics and hormonal responses to intravenous angiotensin II infusion in hypertensive patients.
    Fridman KU; Elmfeldt D; Wysocki M; Friberg PR; Andersson OK
    Blood Press; 2002; 11(4):244-52. PubMed ID: 12361194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
    Solomon SD; Appelbaum E; Manning WJ; Verma A; Berglund T; Lukashevich V; Cherif Papst C; Smith BA; Dahlöf B;
    Circulation; 2009 Feb; 119(4):530-7. PubMed ID: 19153265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
    Ito A; Egashira K; Narishige T; Muramatsu K; Takeshita A
    Jpn Circ J; 2001 Sep; 65(9):775-8. PubMed ID: 11548874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simvastatin treatment in subjects at high cardiovascular risk modulates AT1R expression on circulating monocytes and T lymphocytes.
    Marino F; Guasti L; Cosentino M; Rasini E; Ferrari M; Maio RC; Loraschi A; Cimpanelli MG; Schembri L; Legnaro M; Molteni E; Crespi C; Crema F; Venco A; Lecchini S
    J Hypertens; 2008 Jun; 26(6):1147-55. PubMed ID: 18475152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.